This paper examines the interplay between industrial and academic research and explores how innovation stimulated by the Royal Society has influenced technological development in business and industry over the past 50 years. The trend for universities to foster the creation of spin-out companies has grown significantly over the past 20 years, while universities and government simultaneously appreciated the potential value of intellectual property and increasingly formalized interaction between industry and academia. Before this the flow of ideas, discoveries and technology from universities to industry relied largely on individuals. Examples of how academics, industrialists and Fellows of the Royal Society have influenced and contributed to industrial research and the world's technology base are explored. The paper examines the supportive role played by the Royal Society through research grants, innovation awards and distinguished Research Fellowships such as the Industry Fellowships Scheme. The most recent initiative to support scientific and technological ventures shows a new direction for the Royal Society in contributing to innovation through its Enterprise Fund.
INTRODUCTION
One of the establishing features of the Royal Society was that it would be a force to benefit the British economy. In this respect the role that the Royal Society has to play in technological innovation in industry remains an important part of its portfolio.
Technology innovation and its industrial application first became strongly evident during the industrial revolution of the eighteenth and nineteenth centuries when individuals such as Robert Stephenson, James Watt, Humphry Davy and Michael Faraday, all Fellows of the Royal Society, came to the fore and were celebrated for their contributions to both technology and the economy. The pace of scientific innovation and its acceptance by the public and business community increased during the twentieth century. The appreciation that science makes important contributions to society became especially evident with major breakthroughs in medicine and health, such as Fleming's discovery of penicillin for treating bacterial infections, which drove the early growth of the pharmaceutical industry in the middle of the last century. Progressively the process of discovery and the monetary or strategic value that may be created have been recognized by businesses and governments. This has led to a move away from associating invention and discovery purely with individuals, and many important inventions and discoveries are now made within a corporate environment in large research and development organizations, funded by major technology companies.
THE ROLE OF UNIVERSITIES IN INNOVATION AND INDUSTRY
Academia continues to have a very important role both in fundamental science and in the initial development of technological discoveries. The importance of this to both the institutions and the nation's economy has been appreciated in recent years by both government and the universities themselves. Mowery and Rosenberg wrote in 1989 that they believed in the benefits of greater industrial involvement in university research, which at the time was counter to the concerns present in both the USA and UK.
1 They commented on the effectiveness in the USA of universities contributing to industrial research, especially through the education of large numbers of engineers and scientists, and contrasted this with British industrial research, which at the time they viewed as limited by low university enrolment. They also discussed the effectiveness of public policy towards technology.
Collaboration in research and development between universities and industry started to increase after World War II, when industry needed the resources and expertise of academic researchers to strengthen their product development capabilities. Arrow, in his much cited paper of 1959, discussed the funding of 'invention' by public bodies, including universities, and the interplay with the private sector from the perspective of the economic value and impact of invention. 2 Over the past 25 years the recognition and engagement of universities with the innovation, knowledge transfer and technology transfer process has increased dramatically. Up to 1980 the exploitation of innovation in universities had in general been very much left to individual scientists and engineers and their own entrepreneurial interests, with the possible exception of the recognition of the value of drug discovery, which some universities already benefited from financially. Examples of companies that were formed by entrepreneurial academics, but without the support of their universities, include Oxford Instruments in 1959 and Filtronic in 1977. Oxford Instruments was founded by Martin and Audrey Wood with an academic base in Oxford's Physics Department. Filtronic was founded by David Rhodes, exploiting his microwave filter research interests that he had established in the Department of Electronic and Electrical Engineering at Leeds.
After this time, interest in the commercial exploitation of research by UK universities led to the formation of spin-out companies and the recognition of benefits from licensing of intellectual property. Richards 3 describes the growth of the spin-out culture at Oxford during the past 20 years and the process and funding routes that facilitate the growth of successful companies from research and intellectual property created in universities.
The rise of interest in universities engaging in technology enterprise activities probably has its roots in the USA in the middle of the twentieth century. Stanford, Massachusetts Institute of Technology (MIT) and Harvard strongly influenced the emergence of The UK has generally had a more risk-averse approach to funding innovation, and although the National Research Development Corporation was established in 1948 to commercialize inventions created using publicly funded research, the UK did not see any significant growth in academic enterprise until the early 1980s. This coincided with a change in taxation policy in the UK, which encouraged venture capital funding, often necessary to fund new technology companies. In 1987, universities were formally recognized as owning intellectual property developed with government funding and were encouraged to engage more strongly in knowledge transfer. Since then, knowledge transfer and enterprise activities, often based around technology, have grown dramatically and in 2008 the Higher Education Funding Council for England reported that UK higher education institutions generated £1.3 billion in knowledge transfer, growing at a rate of 20% while generating 220 spin-out companies in that year. In 2007/08 university spin-outs employed close to 14 000 staff with a turnover of £1.1 billion. 4 The Royal Society's report The scientific century: securing our future prosperity recognizes that, over the past 15 years, UK universities have responded vigorously to the challenge of increasing knowledge transfer into industry. 5 It also recognizes that the support and incentives that our universities receive have key roles in encouraging translation, commercialization and knowledge exchange. The past 10 years have seen increased investment in research and support for innovation in the UK's public sector and this has stimulated considerable activity between universities, industry and business. In the nine years to 2008, the number of patents granted to universities rose by 136% and consultancy income rose by 222%. The establishment of the Technology Strategy Board (TSB), initially as an advisory board to government departments in 2004 and subsequently as an independent body (at 'arm's length' from government) in July 2007, has had a significant impact on accelerating innovation and creating value in technology companies. The TSB supports the Knowledge Transfer Partnerships, which have proven extremely effective in linking Technological innovation in industry S57 university research and support to small to medium-sized enterprises (SMEs), and Knowledge Transfer Networks for several science, engineering and technology-based sectors. Innovation Platforms have been implemented, which are programmes intended to stimulate innovative solutions within UK businesses.
Many innovations and the route to exploitation often require multidisciplinary expertise. Universities present an ideal environment in which to nucleate multidisciplinary and interdisciplinary research and innovation. The rise in multidisciplinary research led the Royal Society to introduce its successful Interface, a journal which is a collaborative venture developed in conjunction with the Engineering and Physical Sciences Research Council. This has been instrumental in supporting cross-disciplinary relationships between engineering and physical sciences and life sciences in the UK. In less than three years, Interface became the fourth most highly cited interdisciplinary journal in the world, behind Science, Nature and Proceedings of the National Academy of Sciences. It was developed in response to pressure from scientists who were finding few places to publish interdisciplinary work that bridged the physical and life sciences, such as the mathematical modelling of infectious diseases or the engineering of new organisms. Interface is ideal for supporting the dissemination of discoveries in the area of synthetic biology where the investigators are drawn from disciplines as diverse as engineering, biology and computer science. The Royal Society is now planning a cross-disciplinary journal, to be called Interface Focus, with publication online and in printed form.
SUPPORTING RESEARCHERS AND INNOVATORS
Support for individuals engaged in innovation has relied historically on research council funding or the support of wealthy benefactors. In the early stages of innovation, typically beyond the basic research stage, it used to be difficult to secure funding to allow individuals to develop their ideas to the point at which they could be the basis of a product, company or licence arrangement. This stage of innovation work used to fall outside the remit of research councils; before the formation of organizations such as the Technology Strategy Board and seed funding within universities, many individuals would fail to win the support they needed to take their ideas through to a commercial phase when venture capital, private equity or other sources of funds then become accessible.
The Royal Society's Brian Mercer Awards for Innovation were established in 2001 to provide meaningful funding for individuals or groups to develop an already proven concept or prototype through to the creation of a near-market product for commercial exploitation. This is intended to help facilitate inventors' taking the project to the point at which the prospect of venture capital becomes a reality. Dr Mercer was an enthusiastic inventor and entrepreneur, and these awards aim at encouraging these qualities in the next generation of scientists. Early-stage ideas and concepts can be funded from the Brian Mercer Feasibility Awards scheme, which provides initial support to test the feasibility of a project. This enables holders to investigate the technical and economic feasibility of commercializing an aspect of their scientific research, possibly in conjunction with a third party and to such a point where an industrial or commercial collaboration can be established. These awards are focused in areas of built environment, clean technology, energy, nanoscience and nanotechnology. 
INDUSTRY FELLOWSHIPS
The Royal Society supports more than 600 research appointments through its various schemes. The Society's Industry Fellowships Scheme, which is funded by the Royal
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Society and the UK's Engineering and Physical Sciences Research Council, Biotechnology and Biological Sciences Research Council, Natural Environment Research Council, Rolls-Royce plc and AstraZeneca, seeks to enhance knowledge transfer in science and technology between industry and academia by supporting researchers for up to two years. This scheme allows academic scientists to work on collaborative projects with industry or, alternatively, a scientist or engineer in industry to work on a collaborative project with a research group in a university or not-for-profit organization. It is hoped that this will foster long-term relationships and corporate links. The scheme encourages work with spin-out companies and SMEs. The Society's Leverhulme Trust Senior Research Fellowships support shorter research periods but includes both universities and industrial research organizations.
Although not aimed at industrial collaboration, the Royal Society's Dorothy Hodgkin Fellowships are available to provide support to scientists and engineers at an early stage of their career and are designed to help them to progress to a permanent position. They are aimed specifically at researchers who require a flexible working pattern resulting from personal circumstances including parental or caring responsibilities and health issues. In some cases they can provide a bridge between academic research and real-world application. This may take the form of a traditional link with a technology company ( possibly through sponsorship) or, as a more recent example, some Dorothy Hodgkin Fellows have participated in the Member of Parliament -Scientist pairing scheme, which facilitates a different route to dissemination and public understanding, linking areas such as science and health with politics.
ROYAL SOCIETY FELLOWS AND THEIR ROLE IN INDUSTRY, ENTERPRISE AND TECHNOLOGY TRANSFER
Many technology companies have benefited from the contributions of Fellows of the Royal Society, and in many cases they were founding members of these companies. Among the many Fellows who have founded or played major roles in the growth of technology companies are David Payne, the co-inventor of the erbium-doped fibre amplifier, and the founder of York Technologies (now PK Technology Inc) and SPI Lasers; David Rhodes, who founded Filtronic on the basis of his award-winning filter technologies; Sir Richard Friend, world-renowned for his research on carbon-based semiconductors, and the founder of Cambridge Display Technology and Plastic Logic; Steve Furber, a designer of microcomputers and the principal designer at Acorn and ARM; Peter Lawrenson, the founder of Switched Reluctance Drives (SRD); and Sir Martin Sweeting, the founder of Surrey Satellite Technology, which led to the largest ever cash spin-out of a company from a university.
Other visionary scientists have contributed to innovations that have fundamentally changed the way that scientifically driven industries operate. Such an example is Sir John Sulston, who oversaw the building and establishment of the Wellcome Trust Sanger Institute between 1993 and 1994 and subsequently participated in the mapping, sequencing and analysis of genomes and contributed a major part to the Human Genome Project. What had seemed impossible in the early 1990s had been achieved by Sulston and colleagues within 10 years and is playing a key role in transforming the diagnosis, prevention and treatment of many common diseases. Monoclonal antibodies now account for one-third of all new pharmaceutical treatments and generate more than US$32 billion in market terms. 7 Winter's work has generated more than £300 million for the MRC in royalties from licences issued to 50 companies. Winter went on to found Cambridge Antibody Technology, with his colleague David Chiswell, which was acquired by AstraZeneca in 2006 for £702 million. In the same year, GlaxoSmithKline acquired Domantis for £230 million, which had also been founded by Winter with Ian Tomlinson. These dramatic examples show how science and technology, coupled with support from national research councils, can generate breakthroughs of immense value to society as well as creating enormous economic benefits.
There are also examples of Fellows whose research led to innovation and exploitation in which the Fellow involved decided to support the work of the Royal Society. Sir Edward P. Abraham was a distinguished biochemist who worked on the development of penicillin (working with Howard Florey) and later cephalosporin, an antibiotic used to combat penicillin-resistant bacteria in pneumonia, septicaemia and bronchitis. His patent on cephalosporin generated a substantial income and Abraham used these funds to generate two charitable trusts. The Royal Society and its work were generously supported by these trusts for many years. More recently, and topically, the Royal Society hosted the Innovation Summit in December 2009, organized by leading universities and technology companies to explore the way in which innovation can lead the economy out of recession. It addressed the controversial issue of whether universities that focus on protecting intellectual property are helping or hindering the innovation process.
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FUNDING FOR INNOVATION AND ENTERPRISE
The role of venture capital and private equity in funding start-up businesses and spin-outs has become well established over the past 25 years. The Royal Society Enterprise Fund has been created to make equity investments in innovative early-stage businesses emerging from the science base in the UK and elsewhere. The fund leverages the Royal Society's technical and scientific network, the extensive science policy work and the flexible time horizons for investment. The focus is on early-stage investment opportunities, and the fund is run on a commercial basis. To ensure long-term sustainability, the fund is financed from donations to the 350th Anniversary Campaign. The fund is intended to be evergreen, with financial gains recycled for reinvestment in future innovative technology-based opportunities. The operation of the fund complements the many other activities supported by the Royal Society and is designed to encourage the exploitation of science for societal benefit. Investments are made in start-up companies that can demonstrate they have outstanding scientific innovation and that have real commercial potential. The Royal Society's networks and relationships are used to highlight and then calibrate investment opportunities. The fund has a goal to raise £20 million and seeks to attract external investment activity into early-stage companies and to generate long-term financial returns. It is intended to serve as a model for the successful commercial application of the results of outstanding research.
The Enterprise Fund made its first investment in August 2009 in the company Novacem, which is developing a new generation of carbon-negative cement systems. The technology is based on research from Imperial College London. The annual production of traditional Portland cement is more than 2.5 billion tonnes and is responsible for 5% of global carbon dioxide emissions; cement production is expected to double by 2050. In contrast with Portland cement, Novacem's cement absorbs more carbon dioxide than it emits over its life cycle. Widespread adoption of this revolutionary new material has the potential to transform the cement industry from a significant emitter to a significant absorber of carbon dioxide.
FUTURE DIRECTIONS
The Royal Society's major 2010 policy study The scientific century: securing our future prosperity, which started as The fruits of curiosity, has been reviewing the landscape for UK science and innovation policy and exploring its direction over the next 10-20 years. The study measures the different forms of value created by science, engineering and medicine for the UK's economy and society and considers the role that science will play in equipping Britain to meet future economic, social and environmental challenges. It is clear that universities have an important role in technology innovation and that the Royal Society and its Fellows have a key role in generating future ideas and research and subsequently creating benefits for society and the economy. 
